UBS OCONNOR LLC - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 53 filers reported holding REGULUS THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2014$1,283,000,000
+612.8%
80,000
+300.0%
0.02%
+633.3%
Q1 2014$180,000,0000.0%20,000
-18.0%
0.00%0.0%
Q4 2013$180,000,000
-18.2%
24,400
+4.7%
0.00%
-40.0%
Q3 2013$220,000,00023,2950.01%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
RA Capital Management 4,039,823$26,420,0003.79%
Foresite Capital Management II, LLC 1,750,269$11,447,0003.48%
ARGONAUT CAPITAL MANAGEMENT CORP 75,000$491,0001.65%
Abingworth LLP 327,350$2,138,0001.25%
Trellus Management Company, LLC 100,000$654,0000.96%
Cormorant Asset Management, LP 896,522$5,863,0000.94%
DAFNA Capital Management LLC 90,000$589,0000.58%
ORACLE INVESTMENT MANAGEMENT INC 749,064$4,898,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
View complete list of REGULUS THERAPEUTICS INC shareholders